Global Medical REIT Inc. (GMRE)
NYSE: GMRE · Real-Time Price · USD
8.37
-0.03 (-0.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Global Medical REIT Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Global Medical REIT stock have an average target of 10.88, with a low estimate of 10 and a high estimate of 11.75. The average target predicts an increase of 29.99% from the current stock price of 8.37.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 18, 2024.
Analyst Ratings
The average analyst rating for Global Medical REIT stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg | Berenberg | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +40.38% | Oct 18, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +19.47% | May 13, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +31.42% | May 8, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +43.37% | Mar 6, 2023 |
| Baird | Baird | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 10, 2022 |
Financial Forecast
Revenue This Year
141.07M
Revenue Next Year
147.25M
from 141.07M
Increased by 4.38%
EPS This Year
-0.01
from 0.23
EPS Next Year
0.08
from -0.01
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 146.8M | 162.0M | 168.8M | ||
| Avg | 141.1M | 147.3M | 151.7M | ||
| Low | 134.4M | 136.2M | 139.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 14.8% | 14.6% | ||
| Avg | - | 4.4% | 3.0% | ||
| Low | - | -3.5% | -5.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 0.15 | 0.15 | |
| Avg | -0.01 | 0.08 | 0.08 | |
| Low | -0.03 | - | 0.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | 80.1% | |
| Avg | - | - | - | |
| Low | - | - | -76.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.